When CDK4/6 is inhibited in breast cancer cells with low CCNE1, early adaptation occurs (up to 72 h), resulting in CDK2 activation and increased cyclin E2 (CCNE2) expression, eventually leading to S phase entry [104]. Here, CCNE2 is linked to breast cancer.